Akhondi-Meybodi Mohsen, Akhondi-Meybodi Sara, Vakili Mahmood, Javaheri Zahra
Gastroenterology and Hepatology Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Arab J Gastroenterol. 2016 Sep;17(3):127-130. doi: 10.1016/j.ajg.2016.06.001. Epub 2016 Aug 31.
Colorectal cancer is a major health problem primarily affecting the quality of life (QoL) of both patient and family. With the advances in surgery and novel chemotherapeutic drugs and modalities, survival has increased and the QoL has improved. The aim of this study was to assess QoL in patients with colorectal cancer taking the situation in the Iranian city Yazd from 2006 to 2011 as an example.
This study was conducted on 120 patients who were diagnosed with colorectal cancer within the 5-year period of the study. Different aspects of the patients' lives were assessed using the EORTC Quality of Life Questionnaire (QLQ)-C30 questionnaire, and the results were reported in average aligned score compared with the maximum score of 100.
The mean age of the patients was 60.31±15.71years (range 14-88years). Sixty-three patients were male and 57 female. Further, 85 patients (70.8%) suffered from colon cancer and 34 (28.3%) had rectal cancer. All patients had undergone partial or total colectomies as treatment followed by chemotherapy. The average QoL score was 77.37±8.7 in women and 76.64±8.7 in men. No significant relationship was found between the average QoL score and gender. The average QoL score was 77.28±8.86 for colon cancer and 76.5±8.47 for rectal cancer, which was not statistically significant. The maximum average QoL score was 77.89±8.79 for stage 2 of the disease and the minimum score for stage 3 (75.81±7.66), indicating no significant relationship between the average QoL score and stage of cancer (p=0.89).
The results of the present study revealed that despite clinical efforts in the city of Yazd, the QoL of patients with colorectal cancer is still very poor in physical, social, clinical, and financial aspects.
结直肠癌是一个主要的健康问题,主要影响患者及其家庭的生活质量(QoL)。随着手术以及新型化疗药物和治疗方式的进步,生存率有所提高,生活质量也得到了改善。本研究旨在以伊朗亚兹德市2006年至2011年的情况为例,评估结直肠癌患者的生活质量。
本研究对120例在研究的5年期间被诊断为结直肠癌的患者进行。使用欧洲癌症研究与治疗组织生活质量问卷(QLQ)-C30问卷评估患者生活的不同方面,并将结果报告为与最高分为100分相比的平均对照分数。
患者的平均年龄为60.31±15.71岁(范围14 - 88岁)。63例为男性,57例为女性。此外,85例患者(70.8%)患有结肠癌,34例(28.3%)患有直肠癌。所有患者均接受了部分或全结肠切除术作为治疗,随后进行化疗。女性的平均生活质量评分为77.37±8.7,男性为76.64±8.7。未发现平均生活质量评分与性别之间存在显著关系。结肠癌的平均生活质量评分为77.28±8.86,直肠癌为76.5±8.47,差异无统计学意义。疾病2期的最高平均生活质量评分为77.89±8.79,3期的最低评分为75.81±7.66,表明平均生活质量评分与癌症分期之间无显著关系(p = 0.89)。
本研究结果表明,尽管亚兹德市在临床方面做出了努力,但结直肠癌患者在身体、社会、临床和经济方面的生活质量仍然很差。